Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Non-Hodgkin 7Lymphoma 7Glioblastoma 7Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Multiple Myeloma 4Glioma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Gliosarcoma 3Burkitt Lymphoma 3Brain Neoplasms 3Astrocytoma 3Myelodysplastic Syndromes 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Acute 2Central Nervous System Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Recurrence 1Primary Myelofibrosis 1Pediatric Brain Tumor 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Oligodendroglioma 1

Interventions

Diet, Ketogenic 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pediatric Brain Tumor × Carmustine × Clear all
NCT03591861 2022-12-12

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

Washington University School of Medicine

Phase NA Terminated
2 enrolled

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡